Center for Scientific Review; Notice of Closed Meetings, 40279-40280 [2023-13142]
Download as PDF
Federal Register / Vol. 88, No. 118 / Wednesday, June 21, 2023 / Notices
Program is functioning and improve the
coordination of the scientific activities
within the Institute. The online forum
will allow members of the public to
review the reorganization proposal and
submit comments.
DATES: The public online forum will
become available on June 26, 2023, and
will remain open for five calendar days,
through June 30, 2023. Any interested
person may file written comments by
sending an email to NIBIBorgchange@
nih.gov. The statement should include
the individual’s name, and when
applicable, professional affiliation.
ADDRESSES: The public forum will be
held online, at https://www.nibib.
nih.gov/about-nibib/proposed-orgchanges for the period of time listed
above.
FOR FURTHER INFORMATION CONTACT:
Frank Flannery, Management Analyst,
National Institute of Biomedical Imaging
and Bioengineering, NIH, (301) 451–
0713, NIBIBorgchange@nih.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the NIH Reform Act of 2006 (42
U.S.C. 281(d)(4)), NIBIB will have a
public hearing to discuss the proposed
reorganization plans. This
announcement and the public forum
serve as that notice.
Ann G. Gawalt,
Acting Executive Officer, National Institute
of Biomedical Imaging and Biomedical
Engineering, National Institutes of Health.
[FR Doc. 2023–13098 Filed 6–20–23; 8:45 am]
BILLING CODE 4140–01–P
Dated: June 15, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–13183 Filed 6–20–23; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
lotter on DSK11XQN23PROD with NOTICES1
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Cancer
Centers Study Section (A).
VerDate Sep<11>2014
18:36 Jun 20, 2023
Jkt 259001
Date: August 2, 2023.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel and
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, Maryland 20852.
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W530, Rockville, Maryland 20850,
240–276–6442, ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Liver
Cancer Projects with the Cirrhosis Network.
Date: August 4, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W238, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W238, Rockville, Maryland
20850, 240–276–6371, decluej@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
40279
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Social and Community Influences
Across the Life Course.
Date: July 12–13, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David E. Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
polliode@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
Date: July 13, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stefania Senger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–867–5309, stefania.senger@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Epidemiology and Population
Sciences.
Date: July 17–18, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: James J. Li, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5148,
MSC 7849, Bethesda, MD 20892, 301–806–
8065, lijames@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology A Integrated Review Group;
HIV Molecular Virology, Cell Biology, and
Drug Development Study Section.
Date: July 17–18, 2023.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth A. Roebuck,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
23–003: Short Courses on Innovative
Methodologies and Approaches in the
Behavioral and Social Sciences.
E:\FR\FM\21JNN1.SGM
21JNN1
lotter on DSK11XQN23PROD with NOTICES1
40280
Federal Register / Vol. 88, No. 118 / Wednesday, June 21, 2023 / Notices
Date: July 17, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rochelle Francine
Hentges, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1000C, Bethesda, MD 20892, (301)
402–8720, hentgesrf@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hypersensitivity, Allergies and Mucosal
Immunology (HAMI).
Date: July 18, 2023.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–23–
038: Testing Centers for Development of
Somatic Cell Genome Editing in Model
Organisms (U42).
Date: July 18, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D,.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis-Chronic Fatigue
Syndrome.
Date: July 18, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8515, janzr2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Musculoskeletal, Skin, and Oral
Sciences.
Date: July 18, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
18:36 Jun 20, 2023
Jkt 259001
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, (301) 435–
2406, ariasj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 14, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–13142 Filed 6–20–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FOR FURTHER INFORMATION CONTACT:
Frank Flannery, Management Analyst,
National Institute of Biomedical Imaging
and Bioengineering, NIH, (301) 451–
0713, NIBIBorgchange@nih.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to the NIH Reform Act of 2006 (42
U.S.C. 281(d)(4)), NIBIB will have a
public hearing to discuss the proposed
reorganization plans. This
announcement and the public forum
serve as that notice. More information
can be found at https://www.nibib.
nih.gov/about-nibib/proposed-orgchanges.
Ann G. Gawalt,
Acting Executive Officer, National Institute
of Biomedical Imaging and Biomedical
Engineering, National Institutes of Health.
[FR Doc. 2023–13099 Filed 6–20–23; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Proposed Reorganization
AGENCY:
National Institutes of Health,
HHS.
ACTION:
The National Institute of
Biomedical Imaging and Bioengineering
(NIBIB) will host a public online forum
to enable public discussion of the
Institute’s proposal to establish the
Section on Mechanics and Tissue
Remodeling Integrating Computational
& Experimental Systems (MATRICES).
The proposed reorganization will more
accurately reflect the current structure
by which the Intramural Research
Program is functioning and improve the
coordination of the scientific activities
within the Institute. The online forum
will allow members of the public to
review the reorganization proposal and
submit comments.
DATES: The public hearing will take
place on July 6, 2023, at 2 p.m. using
NIBIB’s social media accounts. Any
interested party may also file written
comments by sending an email to
NIBIBorgchange@nih.gov prior or
during the scheduled public hearing.
The statement should include the
individual’s name, and when
applicable, professional affiliation.
ADDRESSES: The following email address
has been established for comments on
the reorganization: NIBIBorgchange@
nih.gov. The social media platforms that
will be used and monitored during this
hearing are:
• Twitter: @NIBIBgov.
• Facebook: https://
www.facebook.com/nibibgov/.
Frm 00088
Fmt 4703
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2023 Notice of
Supplemental Funding Opportunity
Notice.
SUMMARY:
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sfmt 4703
Substance Abuse and Mental
Health Services Administration,
Department of Health and Human
Services (HHS).
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting one
administrative supplement in scope of
the parent award to the State Opioid
Response (SOR)/Tribal Opioid Response
(TOR) Technical Assistance Grant
recipient, the American Academy of
Addiction Psychiatry (AAAP) funded in
FY 2022 under Notice of Funding
Opportunity (NOFO) TI–22–007 to
provide training and technical
assistance to federally-recognized Tribes
and Tribal organizations.
FOR FURTHER INFORMATION CONTACT:
William Longinetti, Substance Abuse
and Mental Health Services
Administration, 5600 Fishers Lane,
Rockville, MD 20857, telephone 240–
276–1190; email: William.longinetti@
samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Funding Opportunity Title: FY 2022
State Opioid Response (SOR)/Tribal
Opioid Response (TOR) Technical
Assistance TI–22–007.
Assistance Listing Number: 93.243.
Authority: Section 509 of the Public
Health Service Act, as amended.
SUMMARY:
E:\FR\FM\21JNN1.SGM
21JNN1
Agencies
[Federal Register Volume 88, Number 118 (Wednesday, June 21, 2023)]
[Notices]
[Pages 40279-40280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Social and Community Influences Across the
Life Course.
Date: July 12-13, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David E. Pollio, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301)
594-4002, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Respiratory Sciences.
Date: July 13, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stefania Senger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Epidemiology and Population Sciences.
Date: July 17-18, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: James J. Li, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5148, MSC 7849, Bethesda, MD 20892, 301-806-
8065, [email protected].
Name of Committee: Infectious Diseases and Immunology A
Integrated Review Group; HIV Molecular Virology, Cell Biology, and
Drug Development Study Section.
Date: July 17-18, 2023.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD
20892, (301) 435-1166, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-23-003: Short Courses on Innovative Methodologies and
Approaches in the Behavioral and Social Sciences.
[[Page 40280]]
Date: July 17, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rochelle Francine Hentges, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C, Bethesda, MD 20892, (301)
402-8720, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Hypersensitivity, Allergies and Mucosal Immunology (HAMI).
Date: July 18, 2023.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shinako Takada, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-5997,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-23-038: Testing Centers for Development of Somatic Cell
Genome Editing in Model Organisms (U42).
Date: July 18, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D,. Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Myalgic Encephalomyelitis-Chronic Fatigue Syndrome.
Date: July 18, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Roger Janz, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8515,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Musculoskeletal, Skin, and Oral Sciences.
Date: July 18, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD
20892, (301) 435-2406, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: June 14, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-13142 Filed 6-20-23; 8:45 am]
BILLING CODE 4140-01-P